XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$7.93
+0.57 (+7.74%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+488.3% upside
Low Target
$35.62
Average Target
$46.65
High Target
$60.75
Current Price
$7.93
Current
$7.93
$7.93
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Scenario Analysis
Bear Case
$35.62
349.2%
Low target
Base Case
$46.65
+488.3%
Avg target
Bull Case
$60.75
+666.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$10.08
-21.3% from high
52-Week Low
$5.25
+51.0% from low
Target vs 52W High
$46.65
+362.8% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +12.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +15.5% |
| MRK | Buy | 36 | 69% | $159.27 | +23.9% |
| PFE | Hold | 36 | 39% | $33.90 | +26.7% |
| BMY | Hold | 35 | 40% | $174.50 | +169.6% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -36.1% |
| ZTS | Hold | 24 | 54% | $209.87 | +188.8% |